COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing. (June 2021)
- Record Type:
- Journal Article
- Title:
- COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing. (June 2021)
- Main Title:
- COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing
- Authors:
- Peto, Tim
Affron, Dominic
Afrough, Babak
Agasu, Anita
Ainsworth, Mark
Allanson, Alison
Allen, Katherine
Allen, Collette
Archer, Lorraine
Ashbridge, Natasha
Aurfan, Iman
Avery, Miriam
Badenoch, Ellena
Bagga, Priya
Balaji, Rishab
Baldwin, Ella
Barraclough, Sophie
Beane, Carol
Bell, John
Benford, Tracy
Bird, Susan
Bishop, Marina
Bloss, Angela
Body, Richard
Boulton, Rosie
Bown, Abbie
Bratten, Carla
Bridgeman, Chris
Britton, Dominic
Brooks, Tim
Broughton-Smith, Margaret
Brown, Pauline
Buck, Beverley
Butcher, Elaine
Byrne, Wendy
Calderon, Gloria
Campbell, Siobhan
Carr, Olivia
Carter, Penny
Carter, Daniel
Cathrall, Megan
Catton, Matthew
Chadwick, Jim
Chapman, David
Chau, Kevin K.
Chaudary, Tanzina
Chidavaenzi, Shaolin
Chilcott, Samatha
Choi, Bea
Claasen, Hannah
Clark, Simon
Clarke, Richard
Clarke, Dawn
Clayton, Richard
Collins, Kayleigh
Colston, Rima
Connolly, James
Cook, Eloïse
Corcoran, Marie
Corley, Ben
Costello, Laura
Coulson, Caroline
Crook, Ant
Crook, Derrick W.
D'Arcangelo, Silvia
Darby, Mary-Anne
Davis, John
de Koning, Rosaline
Derbyshire, Pauline
Devall, Pam
Dolman, Mark
Draper, Natalie
Driver, Mark
Dyas, Sarah
Eaton, Emily
Edwards, Joy
Elderfield, Ruth
Ellis, Kate
Ellis, Graham
Elwell, Sue
Evans, Rachel
Evans, Becky
Evans, Marion
Evans, Ranoromanana
Eyre, David
Fahey, Codie
Fenech, Vanessa
Field, Janet
Field, Alice
Foord, Tom
Fowler, Tom
French, Mollie
Fuchs, Hannah
Gan, Jasmine
Gernon, Joseph
Ghadiali, Geeta
Ghuman, Narindar
Gibbons, Kerry
Gill, Gurvinder
Gilmour, Kate
Goel, Anika
Gordon, Sally
Graham, Tillie
Grassam-Rowe, Alexander
Green, David
Gronert, Anna
Gumsley-Read, Tegan
Hall, Claire
Hallis, Bassam
Hammond, Sally
Hammond, Peter
Hanney, Beth
Hardy, Victoria
Harker, Gabriella
Harris, Andrew
Havinden-Williams, May
Hazell, Elena
Henry, Joanne
Hicklin, Kim
Hollier, Kelly
Holloway, Ben
Hoosdally, Sarah J.
Hopkins, Susan
Hughes, Lucy
Hurdowar, Steve
Hurford, Sally-Anne
Jackman, Joanne
Jackson, Harriet
Johns, Ruth
Johnston, Susan
Jones, Juliet
Kanyowa, Tinashe
Keating-Fedders, Katie
Kempson, Sharon
Khan, Iftikhar
Khulusi, Beinn
Knight, Thomas
Krishna, Anuradha
Lahert, Patrick
Lampshire, Zoe
Lasserson, Daniel
Lee, Kirsten
Lee, Lennard Y.W.
Legard, Arabella
Leggio, Cristina
Liu, Justin
Lockett, Teresa
Logue, Christopher
Lucas, Vanessa
Lumley, Sheila F.
Maripuri, Vindhya
Markham, Des
Marshall, Emma
Matthews, Philippa C.
Mckee, Sarah
McKee, Deborah F.
McLeod, Neil
McNulty, Antoinette
Mellor, Freddie
Michel, Rachel
Mighiu, Alex
Miller, Julie
Mirza, Zarina
Mistry, Heena
Mitchell, Jane
Moeser, Mika Erik
Moore, Sophie
Muthuswamy, Akhila
Myers, Daniel
Nanson, Gemma
Newbury, Mike
Nicol, Scott
Nuttall, Harry
Nwanaforo, Jewel Jones
Oliver, Louise
Osbourne, Wendy
Osbourne, Jake
Otter, Ashley
Owen, Jodie
Panchalingam, Sulaksan
Papoulidis, Dimitris
Pavon, Juan Dobaldo
Peace, Arro
Pearson, Karen
Peck, Liam
Pegg, Ashley
Pegler, Suzannah
Permain, Helen
Perumal, Prem
Peto, Leon
Peto, Tim E.A.
Pham, Thanh
Pickford, Hayleah L.
Pinkerton, Mark
Platton, Michelle
Price, Ashley
Protheroe, Emily
Purnell, Hellen
Rawden, Lottie
Read, Sara
Reynard, Charles
Ridge, Susan
Ritter, Tom G.
Robinson, James
Robinson, Patrick
Rodger, Gillian
Rowe, Cathy
Rowell, Bertie
Rowlands, Alexandra
Sampson, Sarah
Saunders, Kathryn
Sayers, Rachel
Sears, Jackie
Sedgewick, Richard
Seeney, Laura
Selassie, Amanda
Shail, Lloyd
Shallcross, Jane
Sheppard, Lucy
Sherkat, Anna
Siddiqui, Shelha
Sienkiewicz, Alex
Sinha, Lavanya
Smith, Jennifer
Smith, Ella
Stanton, Emma
Starkey, Thomas
Stawiarski, Aleksander
Sterry, Amelia
Stevens, Joe
Stockbridge, Mark
Stoesser, Nicole
Sukumaran, Anila
Sweed, Angela
Tatar, Sami
Thomas, Hema
Tibbins, Carly
Tiley, Sian
Timmins, Julie
Tomas-Smith, Cara
Topping, Oliver
Turek, Elena
Neibler, Toi
Trigg-Hogarth, Kate
Truelove, Elizabeth
Turnbull, Chris
Tyrrell, David
Vaughan, Alison
Vertannes, John
Vipond, Richard
Wagstaff, Linda
Waldron, Joanne
Walker, Philip
Walker, Ann Sarah
Walters, Mary
Wang, Jenny Y
Watson, Ellie
Webberley, Kate
Webster, Kimerbley
Westland, Grace
Wickens, Ian
Willcocks, Jane
Willis, Herika
Wilson, Stephen
Wilson, Barbara
Woodhead, Louise
Wright, Deborah
Xavier, Bindhu
Yelnoorkar, Fiona
Zeidan, Lisa
Zinyama, Rangeni
… (more) - Abstract:
- Abstract: Background: Lateral flow device (LFD) viral antigen immunoassays have been developed around the world as diagnostic tests for SARS-CoV-2 infection. They have been proposed to deliver an infrastructure-light, cost-economical solution giving results within half an hour. Methods: LFDs were initially reviewed by a Department of Health and Social Care team, part of the UK government, from which 64 were selected for further evaluation from 1st August to 15th December 2020. Standardised laboratory evaluations, and for those that met the published criteria, field testing in the Falcon-C19 research study and UK pilots were performed (UK COVID-19 testing centres, hospital, schools, armed forces). Findings: 4/64 LFDs so far have desirable performance characteristics (orient Gene, Deepblue, Abbott and Innova SARS-CoV-2 Antigen Rapid Qualitative Test). All these LFDs have a viral antigen detection of >90% at 100, 000 RNA copies/ml. 8951 Innova LFD tests were performed with a kit failure rate of 5.6% (502/8951, 95% CI: 5.1–6.1), false positive rate of 0.32% (22/6954, 95% CI: 0.20–0.48). Viral antigen detection/sensitivity across the sampling cohort when performed by laboratory scientists was 78.8% (156/198, 95% CI 72.4–84.3). Interpretation: Our results suggest LFDs have promising performance characteristics for mass population testing and can be used to identify infectious positive individuals. The Innova LFD shows good viral antigen detection/sensitivity with excellentAbstract: Background: Lateral flow device (LFD) viral antigen immunoassays have been developed around the world as diagnostic tests for SARS-CoV-2 infection. They have been proposed to deliver an infrastructure-light, cost-economical solution giving results within half an hour. Methods: LFDs were initially reviewed by a Department of Health and Social Care team, part of the UK government, from which 64 were selected for further evaluation from 1st August to 15th December 2020. Standardised laboratory evaluations, and for those that met the published criteria, field testing in the Falcon-C19 research study and UK pilots were performed (UK COVID-19 testing centres, hospital, schools, armed forces). Findings: 4/64 LFDs so far have desirable performance characteristics (orient Gene, Deepblue, Abbott and Innova SARS-CoV-2 Antigen Rapid Qualitative Test). All these LFDs have a viral antigen detection of >90% at 100, 000 RNA copies/ml. 8951 Innova LFD tests were performed with a kit failure rate of 5.6% (502/8951, 95% CI: 5.1–6.1), false positive rate of 0.32% (22/6954, 95% CI: 0.20–0.48). Viral antigen detection/sensitivity across the sampling cohort when performed by laboratory scientists was 78.8% (156/198, 95% CI 72.4–84.3). Interpretation: Our results suggest LFDs have promising performance characteristics for mass population testing and can be used to identify infectious positive individuals. The Innova LFD shows good viral antigen detection/sensitivity with excellent specificity, although kit failure rates and the impact of training are potential issues. These results support the expanded evaluation of LFDs, and assessment of greater access to testing on COVID-19 transmission. Funding: Department of Health and Social Care. University of Oxford. Public Health England Porton Down, Manchester University NHS Foundation Trust, National Institute of Health Research. … (more)
- Is Part Of:
- EClinicalMedicine. Volume 36(2021)
- Journal:
- EClinicalMedicine
- Issue:
- Volume 36(2021)
- Issue Display:
- Volume 36, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 36
- Issue:
- 2021
- Issue Sort Value:
- 2021-0036-2021-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-06
- Subjects:
- Coronavirus -- COVID-19 -- SARS-CoV-2 -- United kingdom -- Public health -- Lateral flow -- VIral antigen detection -- Testing -- National evaluation -- LFD -- Lateral flow tests -- Lateralflow devices
Medicine -- Research -- Periodicals
Medical policy -- Periodicals
Clinical Medicine
Health Policy
Public Health
Medical policy
Medicine -- Research
Periodical
Electronic journals
Periodicals
613 - Journal URLs:
- https://www.sciencedirect.com/science/journal/25895370 ↗
http://www.sciencedirect.com/ ↗ - DOI:
- 10.1016/j.eclinm.2021.100924 ↗
- Languages:
- English
- ISSNs:
- 2589-5370
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23273.xml